Retinal anti-angiogenesis by a new route.
Bicknell
Roy
R
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods; D006801:Humans; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000378:metabolism*; D012164:Retinal Diseases / Q000188:drug therapy* / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000378:metabolism*
D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A